Health Care & Hospital Law,
Civil Litigation
Jun. 8, 2021
Opioid MDL against McKinsey heads to San Francisco
McKinsey faces accusations that it contributed to an opioid crisis by advising drug manufacturers like Purdue Pharma which deceptively downplayed the risk of addiction in marketing prescriptions.
A new opioid multidistrict litigation is heading to federal court in San Francisco, after the panel overseeing such cases decided Monday several false advertising lawsuits against McKinsey & Co should be kept out of an existing opioid MDL in Ohio.
McKinsey faces accusations that it contributed to an opioid crisis by advising drug manufacturers like Purdue Pharma which deceptively downplayed the risk of addiction in marketing pres...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Civil Litigation
Judge gets several 1,000-page motions from opioid trial plaintiffs
By Blaise Scemama
Civil Litigation
State drops 2 opioid defendants, judge mulls total dismissal
By Blaise Scemama
Civil Litigation
Dismissal motion denied, trial against opioid makers continues
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Drug companies open defense with opioid advocate
By Blaise Scemama
Health Care & Hospital Law
4 pharma companies say state has not made its case in Orange County trial
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Allergan says there’s no false advertising if public never sees it
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Judge denies many untimely filed plaintiffs’ documents in opioid trial
By Blaise Scemama
Criminal, 9th U.S. Circuit Court of Appeals
Defenders seek review of panel’s reinstatement of doctor’s opioid trial
By Gina Kim
Constitutional Law, Civil Litigation
Opioid trials remind us of importance of Brady rights
By Nina Marino
